StockData
Serina Therapeutics, Inc. logo

Serina Therapeutics, Inc. (SER) stock

SERNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$1.36−0.05 (-3.87%)

Close on Nov 17, 2026Market cap $34.67MP/E –Yield –

Serina Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Serina Therapeutics's price to sales ratio was 150.7× on Apr 30, 2026, against 6.8× a year earlier. Over the last 5 years it ranged from 0.3× to 477.9×, with a median of 111.4×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 2026150.7×+137.5
2025Jan 31, 202513.2×−0.9
2024Dec 31, 202414.1×−183.3
2023Dec 29, 2023197.4×−197.8
2022Dec 30, 2022395.2×+244.8
2021Dec 31, 2021150.4×+74.2
2020Dec 31, 202076.2×+30.3
2019Dec 31, 201945.9×−25.9
2018Dec 31, 201871.9×–

More Serina Therapeutics figures

See a number that looks wrong?